UNIVERSAL CLL1 CAR-T

Clinical trials for UNIVERSAL CLL1 CAR-T explained in plain language.

Never miss a new study

Get alerted when new UNIVERSAL CLL1 CAR-T trials appear

Sign up with your email to follow new studies for UNIVERSAL CLL1 CAR-T, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Universal 'Off-the-Shelf' cell therapy trial launches for aggressive leukemia

Disease control Not yet recruiting

This early-phase study is testing a new type of 'universal' CAR-T cell therapy for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. The therapy uses donor immune cells engineered to target a protein called CLL1 found on most AML …

Matched conditions: UNIVERSAL CLL1 CAR-T

Phase: PHASE1 • Sponsor: Mingfeng Zhao • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

UNIVERSAL CLL1 CAR-T

Get alerted when new UNIVERSAL CLL1 CAR-T trials appear

Universal 'Off-the-Shelf' cell therapy trial launches for aggressive leukemia